Trofosfamide (Ixoten)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 23:54, 31 July 2023 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Note: this drug appears to only be approved in Germany.

Mechanism of action

Nitrogen mustard, alkylating agent

Also known as

  • Brand name: Ixoten